|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Iteos Therapeutics, Inc. (ITOS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
37,960,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
5,000 |
5,000 |
Total Buy Value |
$0 |
$0 |
$41,850 |
$41,850 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
0 |
0 |
350,000 |
350,000 |
Total Sell Value |
$0 |
$0 |
$5,692,673 |
$5,692,673 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
1 |
1 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-09-21 |
4 |
AS |
$27.47 |
$902,609 |
I/I |
(32,858) |
5,543,354 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-09-20 |
4 |
AS |
$27.03 |
$668,008 |
I/I |
(24,303) |
3,397,322 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-09-20 |
4 |
AS |
$27.03 |
$1,117,964 |
I/I |
(40,673) |
5,576,212 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-09-20 |
4 |
AS |
$27.03 |
$668,008 |
I/I |
(24,303) |
3,397,322 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-09-17 |
4 |
AS |
$28.82 |
$1,317,016 |
I/I |
(45,698) |
3,421,625 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-09-17 |
4 |
AS |
$28.82 |
$2,203,952 |
I/I |
(76,473) |
5,616,885 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-09-17 |
4 |
AS |
$28.82 |
$1,317,016 |
I/I |
(45,698) |
3,421,625 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-09-16 |
4 |
AS |
$28.47 |
$605,073 |
I/I |
(21,253) |
3,467,323 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-09-16 |
4 |
AS |
$28.47 |
$1,012,536 |
I/I |
(35,565) |
5,693,358 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-09-16 |
4 |
AS |
$28.47 |
$605,073 |
I/I |
(21,253) |
3,467,323 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-09-15 |
4 |
AS |
$27.79 |
$670,207 |
I/I |
(24,104) |
3,488,576 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-09-15 |
4 |
AS |
$27.79 |
$1,121,535 |
I/I |
(40,336) |
5,728,923 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-09-15 |
4 |
AS |
$27.79 |
$670,207 |
I/I |
(24,104) |
3,488,576 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-09-14 |
4 |
AS |
$27.50 |
$594,703 |
I/I |
(21,561) |
3,512,680 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-09-14 |
4 |
AS |
$27.50 |
$995,198 |
I/I |
(36,081) |
5,769,259 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-09-14 |
4 |
AS |
$27.50 |
$594,703 |
I/I |
(21,561) |
3,512,680 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-09-13 |
4 |
AS |
$27.64 |
$591,054 |
I/I |
(21,384) |
3,534,241 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-09-13 |
4 |
AS |
$27.64 |
$591,054 |
I/I |
(21,384) |
3,534,241 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-09-13 |
4 |
AS |
$27.64 |
$989,097 |
I/I |
(35,785) |
5,805,340 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-09-10 |
4 |
AS |
$27.86 |
$382,864 |
I/I |
(13,531) |
3,555,625 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-09-10 |
4 |
AS |
$27.86 |
$382,864 |
I/I |
(13,531) |
3,555,625 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-09-10 |
4 |
AS |
$27.86 |
$640,691 |
I/I |
(22,643) |
5,841,125 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-09-09 |
4 |
AS |
$28.97 |
$658,343 |
I/I |
(22,725) |
3,569,156 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-09-09 |
4 |
AS |
$28.97 |
$658,343 |
I/I |
(22,725) |
3,569,156 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-09-09 |
4 |
AS |
$28.97 |
$1,101,671 |
I/I |
(38,028) |
5,863,768 |
|
- |
|
229 Records found
|
|
Page 7 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|